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Purpose: In a previous preliminary analysis we reported that mitochondrial DNA (mtDNA) haplogroup R0a was
significantly more frequent in primary angle closure glaucoma (PACG) Saudi patients than in healthy Saudi controls. This
result prompted us to extend our work using a significant larger Saudi PACG cohort and more healthy controls.
Methods:  We  sequenced  the  mtDNA  regulatory  hypervariable  region-I  (HVS-I)  and  coding  regions,  comprising
haplogroup diagnostic polymorphisms, in 227 PACG Saudi patients and compared their haplogroup frequencies with
those obtained from 186 matched healthy controls (free of PACG by examination) and from a large sample of 810 healthy
Saudi Arabs representing the general Saudi population.
Results: MtDNA Haplogroups R0a and J, the most abundant lineages in Saudi Arabia, were in significant higher
frequencies in the PACG patients than in controls, while the widespread western Eurasian haplogroup U was associated
with reduced risk to developing PACG.
Conclusions: Haplogroups R0a and J could be ancestry informative markers for PACG in the Saudi Arabian population.
In addition, the western Eurasian haplogroup U may play a mild protective effect to this illness.
Although glaucoma embodies a heterogeneous group of
optic neuropathies, all types are defined by progressive and
irreversible  degeneration  of  the  optic  nerve  with  gradual
visual field loss. Within this group, primary angle-closure
glaucoma (PACG) is a type of glaucoma characterized by a
narrow  iridocorneal  angle  resulting  in  a  blockage  of  the
aqueous outflow structures. It seems that there is an anatomic
and  physiologic  predisposition  to  PACG.  Thus,  shallow
anterior  chamber  depth  is  considered  an  anatomically
inheritable risk factor for this illness [1]. Congruently, Eastern
Asian ascendance, hyperopia and female gender significantly
predispose to this disease [2]. It has been estimated that in
Saudi Arabia, 40% of glaucoma patients belong to the PACG
type [3]. This percentage is closer to those calculated for Asian
than  for  European  populations  [4].  Although  a  hereditary
component for PACG exists, causative genes have not yet
been  identified  and  only  occasional  differences  in  gene
frequency polymorphisms or in levels of gene expression
between  PACG  patients  and  healthy  controls  have  been
reported. For instance, mutations in the myocilin (MYOC)
gene were observed in PACG Chinese patients but also in
Chinese  controls  ruling  out  a  role  of  this  gene  in  the
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pathogenesis of PACG [5]. The C677T polymorphism in the
methylenetetrahydrofolate  reductase  (MTHFR)  gene  was
found associated with PACG in a Pakistani cohort [6], but this
result has not been extended to other populations. The possible
role of mitochondrial abnormalities (mtDNA mutations and
respiratory activity) in PACG was investigated and authors
found  minimal  evidence  of  such  abnormalities  [7].  A
significant increase of SPARC (secreted protein, acidic, and
rich in cysteine) in the iris of PACG patients compared to
healthy  controls  has  also  been  documented  pointing  to  a
possible role of this gene in the development of PACG [8].
However, these results have not yet been confirmed. PACG
is also characterized by an increase of intraocular pressure
(IOP). Recently it has been demonstrated experimentally that
elevated hydrostatic pressure induces mitochondrial structural
changes and apoptotic cell death which suggests, once more,
a  possible  role  of  mitochondrial  injury  in  glaucoma  [9].
Significant  associations  between  mitochondrial  DNA
(mtDNA) haplogroups and different types of glaucoma have
been  detected  in  the  Saudi  Arabia  population  [3,10].
Furthermore,  in  a  preliminary  pilot  experiment,  a  highly
significant prevalence of mtDNA haplogroup preHV1 (now
named R0a) in a small cohort of 29 PACG Saudi patients was
found [11]. The aim of the present study was to evaluate the
possible role of mtDNA Haplogroup(s) in large cohort of
PACG Saudi patients with special emphasis to confirm the
susceptibility  to  PACG  for  carriers  of  R0a,  the  most
Molecular Vision 2011; 17:2171-2176 <http://www.molvis.org/molvis/v17/a235>
Received 25 July 2011 | Accepted 8 August 2011 | Published 12 August 2011
© 2011 Molecular Vision
2171representative mtDNA haplogroup in the Arabian peninsula
[12].
METHODS
Patients and control subjects: We recruited 227 Saudi PACG
patients  who  satisfied  strict  clinical  criteria  for  PACG.
Patients were eligible for inclusion if they had evidence of
glaucomatous  optic  nerve  damage  attributable  to  primary
angle closure [13]. Inclusion criteria included at least three of
the following: 1) clinical documentation of angle closure,
defined as the presence of appositional or synnechial closure
of the anterior chamber angle involving at least 270 degrees
by gonioscopy in either eye; 2) intraocular pressure elevated
to a level ≥21 mmHg measured by Goldmann applanation
tonometry  before  or  after  treatment;  3)  evidence  of
characteristic  glaucomatous  optic  disk  damage  with
excavation  of  the  disc  causing  a  cup-to-disk  ratio  (c/d)
vertically  of  at  least  0.70  in  at  least  one  eye;  and  4)
characteristic peripheral visual field loss including nerve fiber
bundle  defects  (nasal  step,  arcuate  scotoma,  paracentral
scotoma)  or  advanced  visual  field  loss  (central  and/or
temporal  island  of  vision)  as  tested  by  Humphrey  Field
Analyzer in those patients with vision better than 20/200 or
Goldmann  Manual  Perimetry  in  those  with  worse  vision.
Exclusion  criteria  included:  1)  secondary  angle  closure
glaucoma; 2) presence of pseudoexfoliation syndrome even if
coexistent with angle closure; 3) another cause of optic nerve
injury affecting either eye; 4) significant visual loss in both
eyes not associated with glaucoma; 5) inability to visualize
the  fundus  for  optic  disk  assessment;  or  6)  refusal  to
participate. Patients were recruited from the glaucoma clinic
at King Abdulaziz University Hospital (KAUH) after signing
an  informed  consent  approved  by  the  institutional  review
board (proposal number # 08–657).
A second group (n=186) of healthy Saudi Arabs controls
(HMC  group)  free  from  glaucoma  by  examination  were
recruited.  Entry  criteria  for  those  subjects  were  age  >40,
normal IOP, open angles on gonioscopy, and normal optic
nerves on examination.
A third large sample (n=810) of healthy Saudi Arabs
(HSA), representing all five major Saudi Arabian provinces,
that were recruited previously for population genetics studies,
was used for statistical comparisons. All individuals of this
group  were  Saudi  Arabs  who  reported  no  symptomatic
metabolic,  genetic,  ocular  disorders  or  any  ophthalmic
problem  on  an  extensive  questionnaire  regarding  family
history, past medical problems, and current health. For those
controls, their mother’s ancestral origin was established as a
Saudi. The mtDNA haplogroup assignation for 552 subjects
of this sample has been already published [11]. All patients
and controls were maternally unrelated Saudi Arabs, all whose
known ancestors were of Saudi Arabian origin. This research
followed the tenets of the Declaration of Helsinki.
DNA  extraction:  Five  milliters  of  peripheral  blood  were
collected in EDTA tubes from all participating individuals.
DNA was extracted using the illustra blood genomicPrep Mini
Spin Kit from GE Healthcare (Buckinhamshire, UK), and
stored at −20 °C in aliquots until required.
Mitochondrial  haplogroup  assortment:  All  samples  were
amplified and sequenced for the mtDNA regulatory region
hypervariable segment I (HVS I) I using previously described
primers and conditions [14] (Table 1). Briefly, each 25 µl PCR
reaction contained 2.5 µl of 10× reaction buffer with MgCl2
(Amersham Pharmacia Biotech, Piscataway, NJ), 10 ρmol of
each  primer,  100  ρmol/µl  each  of  deoxynucleoside
triphophates (deoxyadenosine triphosphate, deoxyguanosine
triphosphate,  deoxycytidine  triphosphate  and
deoxythymidine  triphosphate;  Perkin-Elmer  Corporation,
Foster  City,  CA)  in  Tris  HCl  buffer,  1  unit  Taq  DNA
polymerase (Amersham Pharmacia Biotech, Piscataway, NJ)
and 50 ng genomic DNA template. The mixture was denatured
at 95 °C for 5 min and the PCR reaction was carried out for
35 cycles, in a GeneAmp 9700 PCR system (Perkin-Elmer
Corporation), under the following conditions: denaturation at
95 °C for 1 min, annealing at 54 °C for 45 s, extension at 72
°C for 1 min, and final extension cycle of 72 °C for 7 min. The
PCR products were electrophoresed on a 1% agarose gel and
detected with 0.5 µg/ml ethidium bromide to confirm the
correct amplicon size. Haplotypes were tentatively assorted
into haplogroups according to their HVS diagnostic positions.
This assortment was further confirmed, when necessary, by
the  analysis  of  coding-region  diagnostic  haplogroup
polymorphisms (Table 2), following the most recent mtDNA
haplogroup  nomenclature  [15].  To  detect  these
polymorphisms a fragment spanning the diagnostic position
was amplified and sequenced using any of the 32 overlapping
pairs of primers that cover the whole mtDNA genome, and the
PCR and sequencing conditions previously published for each
of them [14].
Statistical  analysis:  Differences  in  haplogroup  frequency
between  patient  and  control  groups  were  tested  by  2×2
contingence tests or by Fisher's exact tests when appropriate.
To keep statistically adequate haplogroup sub-sample sizes
within cohorts, when necessary, mtDNA haplogroups were
collapsed  into  larger  haplogroup  identities  following
phylogenetic  criteria  [15].  Genetic  diversity,  h,  within
haplogroups  and  its  variance  were  estimated  from  the
unbiased formulas given by Nei [16], as implemented in the
Arlequin 3.5 package. Differences in h were performed using
a standard two-tailed z test. Finally the geographic origin
distributions of patients and matched controls and differences
in haplogroup frequencies among Saudi Arabian provinces
were compared by 2×n contingency tests.
RESULTS
As women have been reported to be at higher risk for PACG
than men [17], and as gender was not a selective criteria in the
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Primer # Primer Sequence Annealing temp. Product size
MIT-1-F CCTCCCTGTACGAAAGGACA 57 614
MIT-1-R TGAGATTGTTTGGGCTACTGC    
MIT-2-F CGAGCAGTAGCCCAAACAAT 57 664
MIT-2-R TTTTGGATTCTCAGGGATGG    
MIT-3-F CCATCCCTGAGAATCCAAAA 57 653
MIT-3-R ATTTTGCGTAGCTGGGTCTG    
MIT-4-F TAAACCAGACCCAGCTACGC 55 661
MIT-4-R AAAGTGGCTGATTTGCGTTC    
MIT-5-F TCAACTGAACGCAAATCAGC 60 784
MIT-5-R TGAAATTGATGGCCCCTAAG    
MIT-6-F CTTAGGGGCCATCAATTTCA 57 705
MIT-6-R AAGCCTCCTATGATGGCAAA    
MIT-7-F GCCATCATAGGAGGCTTCATT 59 702
MIT-7-R TTTCCTGAGCGTCTGAGATGT    
MIT-8-F CATCTCAGACGCTCAGGAAA 55 730
MIT-8-R GGGAGGTAGGTGGTAGTTTGTG    
MIT-9-F TACTACCGTATGGCCCACCA 60 781
MIT-9-R AGGCTTGGATTAAGGCGACA    
MIT-10-F ACTGACTATCCTAGAAATCGCTGT 59 741
MIT-10-R GCAGATAGTGAGGAAAGTTGAGC    
MIT-11-F CCACGGACTTCACGTCATTA 59 743
MIT-11-R GGGAGGATATGAGGTGTGAGC    
MIT-12-F GCATTTACCATCTCACTTCTAGG 57 751
MIT-12-R AGTGCGATGAGTAGGGGAAG    
MIT-13-F AGGCACATACTTCCTATTCTACACC 55 740
MIT-13-R TGATATTTGATCAGGAGAACGTG    
MIT-14-F ACTGGGAGAACTCTCTGTGCT 55 740
MIT-14-R ACGAACAATGCTACAGGGATG    
MIT-15-F TCCATAATATTCATCCCTGTAGCA 57 741
MIT-15-R GTGGGTACAGATGTGCAGGA    
MIT-16-F GTTACAATCGGCATCAACCA 55 740
MIT-16-R AGCTTTTCTAGTCAGGTTAGGTCTA    
MIT-17-F CCTCAACCCAAAAAGGCATA 59 745
MIT-17-R GGAGGTCGATGAATGAGTGG    
MIT-18-F ACGCAAAATTAACCCCCTAA 59 742
MIT-18-R GCCTAGGAGGTCTGGTGAGA    
MIT-19-F CCTAGGCGACCCAGACAAT 59 740
MIT-19-R GATAGTTGAGGGTTGATTGCTGTA    
MIT-20-F TGCTTACAAGCAAGTACAGCAAT 57 370
MIT-20-R TGATGTCTTATTTAAGGGGAACG    
MIT-21-F GGCTCACATCACCCCATAAA 55 720
MIT-21-R CATGGGCTACACCTTGACCT    
MIT-22-F GCAAACCCTGATGAAGGCTA 57 632
MIT-22-R GGGGTCTTAGCTTTGGCTCT    
MIT-23-F ACTTTGCAAGGAGAGCCAAA 59 672
MIT-23-R AGGCGGTGCCTCTAATACTG    
MIT-24-F TCACCTCTAGCATCACCAGTATT 57 660
MIT-24-R GGAAGGCGCTTTGTGAAGTA    
HVS-I-F ACT TCA CAA CAA TCC TAA TCC T 60 1200
HVS-I-R CGG AGC GAG GAG AGT AGC AC    
HVS-II-F CAT TTA CCG TAC ATA GCA CA 60 820
HVS-II-R GGG AGG GGG TGA TCT AAA AC    
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ratio between both cohorts. Among patients, the female to
male ratio (1.34:1) was significantly higher (p=0.047) than in
controls (0.94), pointing to a greater female susceptibility to
PACG in the Saudi population. However, mtDNA haplogroup
frequencies  did  not  differ  between  sexes  in  any  group.
Haplogroup  frequencies  obtained  for  the  PACG  patients,
healthy  matched  controls  (HMC)  and  the  general  Saudi
population  (HSA)  is  listed  in  Table  2.  Although  mtDNA
haplogroup R0a was abundant in PACG (22.5%) than in HMS
(14.0%) and HSA (17.4%), only the PACG*HMS comparison
reached  statistical  significance  (Table  2).  Additionally,
Haplogroup J, which is the most representative of the whole
Saudi Arabia population [12], was found in higher frequencies
in the patients group (28.2%) than in HMS (25.3%) and HSA
(21.1%)  controls.  In  this  case  only  the  PACG*HSA
comparison reached statistical significance (p=0.02). Finally,
haplogroup U was significantly underrepresented in PACG
patients (6.2%) compared to both the HMS (13.4%) and HSA
(11.2%) control groups (Table 2) pointing to a consistent
protective effect of this haplogroup to PACG.
DISCUSSION
By studying the prevalence of various mtDNA hpalogroups
in 227 PACG Saudi patients and compare this to a large cohort
of population controls (n=810) and to a group of individuals
with no PACG by examination (healthy controls, n=186), we
found  that  Haplogroups  R0a  and  J  could  be  ancestry
informative  markers  for  PACG  in  the  Saudi  Arabian
population. In our previous study [11], we also found an
association (p=0.00002) between mtDNA haplogroup R0a
and PACG in a smaller cohort of Saudi Patients (n=29). The
level of significance, for the R0a, found here (p=0.03) is lower
than in our previous study [11]. The difference observed in
the level of statistical significance could be explained, at first
sight,  by  an  ascertainment  bias  for  the  previous  PACG
sampling due to its small sample size (n=29). An associated
consequence we could expect of it would be a concomitant
diminution in its haplotype diversity (h) within haplogroup
R0a. However, h values (Table 3) for the past and present
PACG samples are very similar and not significantly different
from controls (p=0.38). In addition, our PACG sample seems
to be as diverse as controls for the J (p=0.20) and U (p=0.76)
for which significant differences between the patient and one
or  both  control  cohorts  were  found  (Table  2).  Population
genetic substructure in Saudi Arabia could also be a possible
confounding  factor.  In  fact,  it  was  found  in  previous
population  studies  that  the  mtDNA  haplogroup  frequency
distribution  in  Arabia  was  geographically  structured  [12].
Focusing into the haplogroups that showed associations with
PACG, there are significant differences in their geographic
frequency distributions, across the five main provinces of
Saudi Arabia, for R0a (p=0.04), with a frequency range from
western (8%) to center (22%), and for J (p=0.002), with a
frequency range from western (37%) to northern (16%). Only
haplogroup U seems to have a uniform distribution across the
country (p=0.63). However, the geographic origin distribution
of the recruited PACG patients and HMS matched controls
(Table 4) was strikingly similar (p=0.42) discarding wide
inter-regional genetic differentiation as a main cause of the
PACG and mtDNA haplogroup associations found. With the
information at hand, we would attribute the R0a frequency
differences  found  between  the  two  independent  PACG
samples to biased sampling of the previous one due to its small
TABLE 2. MTDNA HAPLOGROUP DISTRIBUTION IN PACG PATIENTS AND CONTROLS.
Haplogroup Coding positions PACG
(n=227)
HMS
(n=186)
  HSA
(n=810)
  PACG * HMS
p value
PACG * HSA
p value
H C7028C 14 (6.2%) 9 (4.8%) 66 (8.1%) 0.56 0.32
R0a T3847C 51 (22.5%) 26 (14.0%) 141 (17.4%) 0.03* 0.08
J T4216C, C15452A 64 (28.2%) 47 (25.3%) 171 (21.1%) 0.51 0.02*
T T4216C, G15928A 11 (4.8%) 9 (4.8%) 53 (6.5%) 0.99 0.35
K A3480G 8 (3.5%) 4 (2.2%) 27 (3.3%) 0.41 0.89
U A12308G, G12372A 14 (6.2%) 25 (13.4%) 91 (11.2%) 0.01* 0.02*
Other R C12705T 6 (2.6%) 8 (4.3%) 25 (3.1%) 0.35 0.73
N1 T10238C, G12501A 12 (5.3%) 13 (7.0%) 66 (8.1%) 0.47 0.15
W G15884C 1 (0.4%) 0 6 (0.7%) 0.37 0.63
X C6371T 8 (3.5%) 4 (2.2%) 20 (2.5%) 0.41 0.39
M1 C10400T C12403T 6 (2.6%) 11 (5.9%) 25 (3.1%) 0.10 0.73
M(xM1)1 C10400T 4 (1.8%) 6 (3.2%) 24 (3.0%) 0.34 0.32
L T9540C, C10400C 28 (12.3%) 24 (12.9%) 95 (11.7%) 0.86 0.80
L2 T10115C 16 (7.0%) 10 (5.4%) 35 (4.3%) 0.49 0.09
L(xL2)2 T9540C, C10400C 12 (5.3%) 14 (7.5%) 60 (7.4%) 0.35 0.27
         ACG, Angle-closed glaucoma patients; HMC, healthy matched controls; HAS, healthy Saudi Arab sample. χ2 or Fisher exact
         test were applied to investigate the association between having a certain haplogroup and the occurrence of ACG.  1All M
         haplogroups except M1. 2All L haplogroups except L2.
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parameters, not yet uncovered, as fine-scale genetic structure
and/or hidden social organization should not be discarded.
In  conclusion,  we  have  detected  a  significant
susceptibility of Saudi R0a carriers to PACG although at a
milder level than the one previously reported. It also seems
likely  that  haplogroup  J,  abundanant  among  the  Saudi
population, also confers a mild susceptibility to PACG. On
the contrary, the western Eurasian widespread haplogroup U
seems to play a mild protective effect to PACG. In a recent
analysis on primary open-angle glaucoma (POAG) in Saudi
Arabia [3], it was found that mtDNA lineages of sub-Saharan
Africa  origin  seemed  to  confer  susceptibility  to  POAG,
pointing to a role of ancestry informative marker for macro-
haplogroup L, as it is well documented that the prevalence of
POAG is higher in subjects of African ascendance [18]. In a
similar  vein,  haplogroups  R0a  and  J  could  reflect  a
predisposition of the genuine Saudi Arabian population to
suffer PACG, which is supported by the high prevalence of
this illness in this Country, near of the range observed for
South and East Asians, and significantly higher than the one
observed for populations of European ascendance [3].
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